~~<i id='8BEBEEF833'><strike id='8BEBEEF833'><tt id='8BEBEEF833'><pre id='8BEBEEF833'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

Wikipedia

author：hotspot 2025-10-02 00:27:43 - browse：25

Roche’s announcement Monday that it would pay $310 million for rights to a hypertension treatment, zilebesiran, invented by the biotech firm Alnylam is evidence of a renewed interest on the part of large pharmaceutical companies for treatments for cardiovascular disease.

If things go well, Roche could pay Alnylam up to $2.8 billion in total.

Heart drugs were once the most lucrative category of pharmaceuticals, but they have been eclipsed by treatments for cancer and other diseases as drug firms have struggled to one-up existing treatments for high blood pressure and high cholesterol that are now available as cheap generics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： UCSF medical school apologizes for unethical prisoner experiments

explore

focus

entertainment

focus

hotspot

AerialviewofCancun,Mexico,whereanewabortionclinicexpectstodrawAmericantravelers.DANIELSLIM/AFPviaGet

WSS

Medicare will require more price transparency from hospitals

Medicare will require more price transparency from hospitals

Diversify hospital leadership teams to protect BIPOC patient health

Free speech concerns arise in wake of journal editor Eisen's firing

Extreme heat events are a public health emergency

Doctors increasingly discourage vaping amid mounting health concerns

focus

Wikipedia

explore

Moonlake's readout produced a cash windfall. Risks remain

What AstraZeneca

Anesthesiologist group: stop taking Ozempic before surgery

Doctors in states that ban abortion can still help patients

In age of alternative facts, a scholarly course on calling out crap

Senate panel clears PBM, hopsital reforms

Walensky prepares to leave CDC — and Congress — behind

'Weather

Hollywood unions extend contract negotiations for actors

More doctors should go into startup world

focus

Ambulance rides for just $100? Advisers want major billing fixes

Ambulance rides for just $100? Advisers want major billing fixes

Victims of gun violence feel impacts long after bullet wound

MoonLake credibility takes another hit with mid

Doctors increasingly discourage vaping amid mounting health concerns

Medicare solvency divides Republicans at the presidential debate

focus

entertainment

focus

hotspot